SCHEMBL21292818

SCHEMBL21292818

O=C(NN=Cc1ccc(Br)cc1)c1ccc(O)cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.58
POLB P06746 5/20 0.58
MEN1 O00255 4/20 0.58
RRM1 P23921 1/20 0.57
GCGR P47871 1/20 0.56
PIK3CG P48736 2/20 0.55
MAPT P10636 2/20 0.55
NPC1 O15118 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
NTRK1 P04629 2/20 0.54
NPSR1 Q6W5P4 1/20 0.54
LMNA P02545 1/20 0.54
PHGDH O43175 1/20 0.53
RAB9A P51151 1/20 0.52
DUSP3 P51452 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292816 1.00 KMT2A (0.58) KMT2APOLBMEN1RRM1GCGR
SCHEMBL20115428 0.91 MEN1 (0.63) KMT2APOLBMEN1RRM1GCGR
SCHEMBL21292852 0.91 MEN1 (0.63) KMT2APOLBMEN1RRM1GCGR
SCHEMBL21292806 0.86 KMT2A (0.58) KMT2APOLBMEN1RRM1GCGR
SCHEMBL20115634 0.86 NPC1 (0.61) KMT2APOLBMEN1RRM1GCGR
SCHEMBL21292804 0.86 KMT2A (0.58) KMT2APOLBMEN1RRM1GCGR
SCHEMBL21292798 0.86 NPC1 (0.61) KMT2APOLBMEN1RRM1GCGR
SCHEMBL20115424 0.86 MEN1 (0.75) KMT2APOLBMEN1RRM1GCGR
SCHEMBL20299057 0.86 MEN1 (0.75) KMT2APOLBMEN1RRM1GCGR
SCHEMBL14448892 0.84 NTRK1 (0.72) KMT2APOLBMEN1RRM1GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD KMT2A 1899/4885POLB 1245/4885MEN1 2502/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD KMT2A 1899/4885POLB 1245/4885MEN1 2502/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD KMT2A 1899/4885POLB 1245/4885MEN1 2502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.